Literature DB >> 20596797

Oxidative stress in Alzheimer disease: synergy between the Butterfield and Markesbery laboratories.

D Allan Butterfield1.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20596797      PMCID： PMC3035764          DOI： 10.1007/s12017-010-8123-9

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN： 1535-1084            Impact factor:   3.843


× No keyword cloud information.
  44 in total

Review 1.  Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.

Authors:  D A Butterfield; J Drake; C Pocernich; A Castegna
Journal:  Trends Mol Med       Date:  2001-12       Impact factor: 11.951

2.  Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis.

Authors:  Marzia Perluigi; Rukhsana Sultana; Giovanna Cenini; Fabio Di Domenico; Maurizio Memo; William M Pierce; Raffaella Coccia; D Allan Butterfield
Journal:  Proteomics Clin Appl       Date:  2009-06-01       Impact factor: 3.494

Review 3.  Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.

Authors:  D Allan Butterfield; Christopher M Lauderback
Journal:  Free Radic Biol Med       Date:  2002-06-01       Impact factor: 7.376

4.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Authors:  C D Smith; J M Carney; P E Starke-Reed; C N Oliver; E R Stadtman; R A Floyd; W R Markesbery
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

5.  Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.

Authors:  Debra Boyd-Kimball; Hafiz Mohmmad Abdul; Tanea Reed; Rukhsana Sultana; D Allan Butterfield
Journal:  Chem Res Toxicol       Date:  2004-12       Impact factor: 3.739

6.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

7.  Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.

Authors:  D Allan Butterfield; H Fai Poon; Daret St Clair; Jeffery N Keller; William M Pierce; Jon B Klein; William R Markesbery
Journal:  Neurobiol Dis       Date:  2006-02-08       Impact factor: 5.996

8.  Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.

Authors:  Hafiz Mohmmad Abdul; Rukhsana Sultana; Jeffrey N Keller; Daret K St Clair; William R Markesbery; D Allan Butterfield
Journal:  J Neurochem       Date:  2006-03       Impact factor: 5.372

Review 9.  Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration.

Authors:  D Allan Butterfield; Debra Boyd-Kimball; Alessandra Castegna
Journal:  J Neurochem       Date:  2003-09       Impact factor: 5.372

10.  Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.

Authors:  Tanea Reed; Marzia Perluigi; Rukhsana Sultana; William M Pierce; Jon B Klein; Delano M Turner; Raffaella Coccia; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2008-01-05       Impact factor: 5.996
View more
  5 in total

Review 1.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

2.  Rhizophora mucronata attenuates beta-amyloid induced cognitive dysfunction, oxidative stress and cholinergic deficit in Alzheimer's disease animal model.

Authors:  Natarajan Suganthy; Dicson Sheeja Malar; Kasi Pandima Devi
Journal:  Metab Brain Dis       Date:  2016-05-17       Impact factor: 3.584

3.  Serum uric acid levels in patients with Alzheimer's disease: a meta-analysis.

Authors:  Xueping Chen; Xiaoyan Guo; Rui Huang; Yongping Chen; Zhenzhen Zheng; Huifang Shang
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

4.  Oxidation Responsive Polymers with a Triggered Degradation via Arylboronate Self-Immolative Motifs on a Polyphosphazene Backbone.

Authors:  Aitziber Iturmendi; Uwe Monkowius; Ian Teasdale
Journal:  ACS Macro Lett       Date:  2017-02-02       Impact factor: 6.903

5.  Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease.

Authors:  Sanghamitra Bandyopadhyay; Catherine Cahill; Amelie Balleidier; Conan Huang; Debomoy K Lahiri; Xudong Huang; Jack T Rogers
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.